Edgewise 制药 EWTX
$45.04 +$6.17 (+15.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $45.28 +0.53%
开盘$39.71
昨收$38.87
当日区间$38.05 – $45.76
成交量3.72M
市值$4.93B
市盈率(TTM)5.4
股息率–
股权结构与仓位
谁在持有、谁在做空,以及大资金的流向
机构持股比例111.7%-0.63 个百分点,较上季度
持仓机构数283-3 ,较上季度
内部人近期交易35次买入 / 15次卖出净买入
空头持仓比例10.82% 占流通股回补天数 8.5 · 截至 15 Oct 2026
卖空成交量占比16.8%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入,近20个交易日
大单买入减卖出的净额(美元)。该窗口期内:−$2.33M(6个净流入日,14个净流出日)。
按单量净流入,近20个交易日
超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。
已披露的前五大股东合计持有43.1%的流通股。
最大股东
按投资者类型
过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从9.14%升至10.82%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +735,202 | 0.7% |
| FMR | Mutual Fund | 2026/Q3 | +4,472,077 | 5.1% |
| Paradigm Biocapital Advisors LP | Hedge Fund | 2026/Q3 | +2,850,417 | 9.4% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +747,091 | 0.8% |
| Tyro Capital Management, LLC | Hedge Fund | 2026/Q3 | +612,965 | 0.6% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +462,000 | 0.4% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +426,597 | 1.2% |
| Integral Health Asset Management, LLC | Hedge Fund | 2026/Q3 | +400,000 | 1.8% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +396,855 | 2.0% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +384,232 | 2.0% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +297,887 | 0.3% |
| Diadema Partners LP | Hedge Fund | 2026/Q3 | +272,214 | 0.3% |
| Parkman Healthcare Partners LLC | Hedge Fund | 2026/Q3 | +254,208 | 0.5% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +250,681 | 4.4% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +229,196 | 0.7% |
按报告期列出的机构买卖动态,变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | Jonathan Fox | Independent Director | Other Acquisition | +308 | – | 25,141 |
| 12 Aug 2026 | Joanne Donovan | Chief Medical Officer | Derivative Exercise and Sale | -9,441 | $44.52 | 8,625 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Derivative Exercise and Sale | -17,971 | $44.33 | 52,488 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Other Derivative Acquisition | +100,000 | – | 100,000 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Other Derivative Acquisition | +200,000 | $43.56 | 200,000 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Derivative Exercise and Retained | +21,873 | – | 52,488 |
| 11 Aug 2026 | John Moore | General Counsel | Derivative Exercise and Sale | -5,016 | $44.50 | 17,697 |
| 11 Aug 2026 | John Moore | General Counsel | Other Derivative Acquisition | +32,500 | – | 32,500 |
| 11 Aug 2026 | John Moore | General Counsel | Other Derivative Acquisition | +65,000 | $43.56 | 65,000 |
| 11 Aug 2026 | John Moore | General Counsel | Derivative Exercise and Retained | +7,483 | – | 17,697 |
| 11 Aug 2026 | Joanne Donovan | Chief Medical Officer | Other Derivative Acquisition | +32,500 | – | 32,500 |
| 11 Aug 2026 | Joanne Donovan | Chief Medical Officer | Other Derivative Acquisition | +65,000 | $43.56 | 65,000 |
| 11 Aug 2026 | Joanne Donovan | Chief Medical Officer | Derivative Exercise and Retained | +3,371 | – | 8,625 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Derivative Exercise and Sale | -5,100 | $44.50 | 31,826 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Other Derivative Acquisition | +50,000 | – | 50,000 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Other Derivative Acquisition | +100,000 | $43.56 | 100,000 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Derivative Exercise and Retained | +8,181 | – | 31,826 |
| 11 Aug 2026 | Michael Nofi | Chief Financial Officer | Other Derivative Acquisition | +24,375 | – | 24,375 |
| 11 Aug 2026 | Michael Nofi | Chief Financial Officer | Other Derivative Acquisition | +48,750 | $43.56 | 48,750 |
| 11 Aug 2026 | Alan Russell | Co-Founder, Chief Scientific Officer & Director | Derivative Exercise and Sale | -5,901 | $44.46 | 31,466 |
数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。
空头持仓(按报告期)
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 11,751,785 | 10.8% | 8.5 |
| 30 Sep 2026 | 11,224,347 | 10.3% | 5.6 |
| 15 Sep 2026 | 9,543,843 | 8.8% | 8.0 |
| 31 Aug 2026 | 9,346,141 | 8.6% | 8.0 |
| 14 Aug 2026 | 9,675,389 | 8.9% | 6.4 |
| 31 Jul 2026 | 9,835,054 | 9.1% | 12.1 |
暂无评论——快来第一个聊聊 EWTX。
登录后参与讨论。